|
1
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
2
|
Herszenyi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.PubMed/NCBI
|
|
3
|
Hyung WJ, Noh SH, Yoo CH, et al:
Prognostic significance of metastatic lymph node ratio in T3
gastric cancer. World J Surg. 26:323–329. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng J, Wu YF, Xu HM, Wang SB and Chen JQ:
Prognostic significance of the metastatic lymph node ratio in T3
gastric cancer patients undergoing total gastrectomy. Asian Pac J
Cancer Prev. 12:3289–3292. 2011.PubMed/NCBI
|
|
5
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zlotnik A: Chemokines in neoplastic
progression. Semin Cancer Biol. 14:181–185. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Righi E, Kashiwagi S, Yuan J, et al:
CXCL12/CXCR4 blockade induces multimodal antitumor effects that
prolong survival in an immunocompetent mouse model of ovarian
cancer. Cancer Res. 71:5522–5534. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marchesi F, Grizzi F, Laghi L, Mantovani A
and Allavena P: Molecular mechanisms of pancreatic cancer
dissemination: the role of the chemokine system. Curr Pharm Des.
18:2432–2438. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balkwill FR: The chemokine system and
cancer. J Pathol. 226:148–157. 2012. View Article : Google Scholar
|
|
11
|
Yao X, Qi L, Chen X, Du J, Zhang Z and Liu
S: Expression of CX3CR1 associates with cellular migration,
metastasis, and prognosis in human clear cell renal cell carcinoma.
Urol Oncol. 32:162–170. 2014. View Article : Google Scholar
|
|
12
|
Wang WN, Chen Y, Zhang YD and Hu TH: The
regulatory mechanism of CCR7 gene expression and its involvement in
the metastasis and progression of gastric cancer. Tumour Biol.
34:1865–1871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marchesi F, Piemonti L, Mantovani A and
Allavena P: Molecular mechanisms of perineural invasion, a
forgotten pathway of dissemination and metastasis. Cytokine Growth
Factor Rev. 21:77–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JH, Cho YS, Lee JY, et al: The
chemokine receptor CCR4 is expressed and associated with a poor
prognosis in patients with gastric cancer. Ann Surg. 249:933–941.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jamieson WL, Shimizu S, D’Ambrosio JA,
Meucci O and Fatatis A: CX3CR1 is expressed by prostate epithelial
cells and androgens regulate the levels of CX3CL1/fractalkine in
the bone marrow: potential role in prostate cancer bone tropism.
Cancer Res. 68:1715–1722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marchesi F, Piemonti L, Fedele G, et al:
The chemokine receptor CX3CR1 is involved in the neural tropism and
malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res.
68:9060–9069. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kodama J, Hasengaowa, Kusumoto T, et al:
Association of CXCR4 and CCR7 chemokine receptor expression and
lymph node metastasis in human cervical cancer. Ann Oncol.
18:70–76. 2007. View Article : Google Scholar
|
|
18
|
Miao Z, Luker KE, Summers BC, et al: CXCR7
(RDC1) promotes breast and lung tumor growth in vivo and is
expressed on tumor-associated vasculature. Proc Natl Acad Sci USA.
104:15735–15740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andre F, Cabioglu N, Assi H, et al:
Expression of chemokine receptors predicts the site of metastatic
relapse in patients with axillary node positive primary breast
cancer. Ann Oncol. 17:945–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meijer J, Zeelenberg IS, Sipos B and Roos
E: The CXCR5 chemokine receptor is expressed by carcinoma cells and
promotes growth of colon carcinoma in the liver. Cancer Res.
66:9576–9582. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shulby SA, Dolloff NG, Stearns ME, Meucci
O and Fatatis A: CX3CR1-fractalkine expression regulates cellular
mechanisms involved in adhesion, migration, and survival of human
prostate cancer cells. Cancer Res. 64:4693–4698. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marchesi F, Monti P, Leone BE, et al:
Increased survival, proliferation, and migration in metastatic
human pancreatic tumor cells expressing functional CXCR4. Cancer
Res. 64:8420–8427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mashino K, Sadanaga N, Yamaguchi H, et al:
Expression of chemokine receptor CCR7 is associated with lymph node
metastasis of gastric carcinoma. Cancer Res. 62:2937–2941.
2002.PubMed/NCBI
|
|
24
|
Brand S, Sakaguchi T, Gu X, Colgan SP and
Reinecker HC: Fractalkine-mediated signals regulate cell-survival
and immune-modulatory responses in intestinal epithelial cells.
Gastroenterology. 122:166–177. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
White GE and Greaves DR: Fractalkine: one
chemokine, many functions. Blood. 113:767–768. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bazan JF, Bacon KB, Hardiman G, et al: A
new class of membrane-bound chemokine with a CX3C motif. Nature.
385:640–644. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lucas AD, Chadwick N, Warren BF, et al:
The transmembrane form of the CX3CL1 chemokine fractalkine is
expressed predominantly by epithelial cells in vivo. Am J Pathol.
158:855–866. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hundhausen C, Misztela D, Berkhout TA, et
al: The disintegrin-like metalloproteinase ADAM10 is involved in
constitutive cleavage of CX3CL1 (fractalkine) and regulates
CX3CL1-mediated cell-cell adhesion. Blood. 102:1186–1195. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Imai T, Hieshima K, Haskell C, et al:
Identification and molecular characterization of fractalkine
receptor CX3CR1, which mediates both leukocyte migration and
adhesion. Cell. 91:521–530. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nevo I, Sagi-Assif O, Meshel T, et al: The
involvement of the fractalkine receptor in the transmigration of
neuroblastoma cells through bone-marrow endothelial cells. Cancer
Lett. 273:127–139. 2009. View Article : Google Scholar
|
|
32
|
Locatelli M, Boiocchi L, Ferrero S, et al:
Human glioma tumors express high levels of the chemokine receptor
CX3CR1. Eur Cytokine Netw. 21:27–33. 2010.PubMed/NCBI
|
|
33
|
Zhao BC, Wang ZJ, Mao WZ, et al:
CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric
carcinoma. World J Gastroenterol. 17:2389–2396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meucci O, Fatatis A, Simen AA and Miller
RJ: Expression of CX3CR1 chemokine receptors on neurons and their
role in neuronal survival. Proc Natl Acad Sci USA. 97:8075–8080.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alessi DR, Andjelkovic M, Caudwell B, et
al: Mechanism of activation of protein kinase B by insulin and
IGF-1. EMBO J. 15:6541–6551. 1996.PubMed/NCBI
|
|
36
|
Gaudin F, Nasreddine S, Donnadieu AC, et
al: Identification of the chemokine CX3CL1 as a new regulator of
malignant cell proliferation in epithelial ovarian cancer. PLoS
One. 6:e215462011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee SJ, Namkoong S, Kim YM, et al:
Fractalkine stimulates angiogenesis by activating the
Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am J
Physiol Heart Circ Physiol. 291:H2836–H2846. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishigami S, Natsugoe S, Okumura H, et al:
Clinical implication of CXCL12 expression in gastric cancer. Ann
Surg Oncol. 14:3154–3158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Murdoch C, Monk PN and Finn A: Functional
expression of chemokine receptor CXCR4 on human epithelial cells.
Immunology. 98:36–41. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Banas B, Wornle M, Berger T, et al: Roles
of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation,
migration, apoptosis, and tissue homeostasis. J Immunol.
168:4301–4307. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schutyser E, Su Y, Yu Y, et al: Hypoxia
enhances CXCR4 expression in human microvascular endothelial cells
and human melanoma cells. Eur Cytokine Netw. 18:59–70.
2007.PubMed/NCBI
|
|
42
|
Ishikawa T, Nakashiro K, Klosek SK, et al:
Hypoxia enhances CXCR4 expression by activating HIF-1 in oral
squamous cell carcinoma. Oncol Rep. 21:707–712. 2009.PubMed/NCBI
|
